Knowles (KN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 Jul, 2026Executive summary
Achieved a breakthrough year, completing the transformation into an industrial technology leader focused on MedTech, Defense, Industrial, and Energy markets, with a proven M&A strategy and strong organic growth driven by custom-engineered solutions.
Revenue and EPS both surpassed the high end of guidance for Q4 and full year 2025, with robust margin expansion and a differentiated competitive advantage through customization at scale.
Strong backlog, new design wins, and robust bookings position the company for continued above-trend growth in 2026.
Financial highlights
Q4 2025 revenue: $162.2M, up 13.8% year-over-year, above guidance; full year 2025 revenue: $593.2M, up 7.2% year-over-year.
Q4 2025 non-GAAP diluted EPS: $0.36, up 33.3% year-over-year; full year 2025 non-GAAP diluted EPS: $1.11, up 20.7%.
Q4 2025 gross margin: 51.9% (non-GAAP: 45.3%); full year 2025 non-GAAP gross margin: 44.5%.
Adjusted EBITDA for 2025 was $140.2M, 23.6% of revenues.
Net cash from operations was $114M for the year, representing 19.2% of revenues.
Outlook and guidance
Q1 2026 revenue guidance: $143M–$153M; non-GAAP diluted EPS expected between $0.22 and $0.26.
Adjusted EBIT margin for Q1 projected at 18%–20%.
2026–2029 targets: 8–10% revenue CAGR, 10–14% adjusted EBITDA CAGR, and 16–20% cash from operations as a percentage of revenue.
Full year capital spending expected to support capacity expansion for large energy orders.
Positioned for continued strong organic revenue growth above historic levels in 2026.
Latest events from Knowles
- Q2 2026 revenue up 14.3% and non-GAAP EPS up 38%, with strong growth outlook.KN
Q2 2026 - Transformation drives strong growth, margin expansion, and new opportunities in resilient markets.KN
16th Annual East Coast IDEAS Conference - Q1 2026 revenue rose 16% to $153.1M, with 50% EPS growth and strong segment margins.KN
Q1 2026 - Annual meeting covers director elections, executive pay, and auditor ratification for 2026.KN
Proxy Filing - 2026 proxy covers director elections, executive pay, auditor ratification, and robust governance.KN
Proxy Filing - Portfolio shift to MedTech, defense, and industrial boosts margins and growth outlook.KN
2024 Southwest IDEAS Conference - Q3 revenue up 32% year-over-year; strategic divestiture and margin gains position for growth.KN
Q3 2024 - Targets 8–10% annual revenue growth and 10–14% EBITDA growth through organic and M&A strategies.KN
Investor Day 2025 - Q1 2025 revenue hit $132.2M, with strong cash flow and higher Q2 growth expected.KN
Q1 2025